These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26413860)

  • 21. The role of inflammation in adjuvant chemotherapy-induced sarcopenia (Izmir Oncology Group (IZOG) study).
    Oflazoglu U; Alacacioglu A; Varol U; Kucukzeybek Y; Salman T; Onal HT; Yilmaz HE; Yildiz Y; Taskaynatan H; Saray S; Butun O; Tarhan MO
    Support Care Cancer; 2020 Aug; 28(8):3965-3977. PubMed ID: 32335732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study.
    Prizment AE; Anderson KE; Visvanathan K; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):297-307. PubMed ID: 21217085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating inflammatory markers and colorectal cancer risk: A prospective case-cohort study in Japan.
    Song M; Sasazuki S; Camargo MC; Shimazu T; Charvat H; Yamaji T; Sawada N; Kemp TJ; Pfeiffer RM; Hildesheim A; Pinto LA; Rabkin CS; Tsugane S
    Int J Cancer; 2018 Dec; 143(11):2767-2776. PubMed ID: 30132835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study.
    Ding C; Parameswaran V; Udayan R; Burgess J; Jones G
    J Clin Endocrinol Metab; 2008 May; 93(5):1952-8. PubMed ID: 18285417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation and sudden cardiac death in a community-based population of older adults: the Cardiovascular Health Study.
    Hussein AA; Gottdiener JS; Bartz TM; Sotoodehnia N; DeFilippi C; See V; Deo R; Siscovick D; Stein PK; Lloyd-Jones D
    Heart Rhythm; 2013 Oct; 10(10):1425-32. PubMed ID: 23906927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating levels of inflammatory cytokines and risk of colorectal adenomas.
    Kim S; Keku TO; Martin C; Galanko J; Woosley JT; Schroeder JC; Satia JA; Halabi S; Sandler RS
    Cancer Res; 2008 Jan; 68(1):323-8. PubMed ID: 18172326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs.
    Chan AT; Ogino S; Giovannucci EL; Fuchs CS
    Gastroenterology; 2011 Mar; 140(3):799-808, quiz e11. PubMed ID: 21115010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance and inflammation mediate the association of abdominal obesity with colorectal cancer risk.
    Li W; Liu T; Qian L; Wang Y; Ma X; Cao L; Zhang Q; Qu J
    Front Endocrinol (Lausanne); 2022; 13():983160. PubMed ID: 36407320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.
    Seddon JM; George S; Rosner B; Rifai N
    Arch Ophthalmol; 2005 Jun; 123(6):774-82. PubMed ID: 15955978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraindividual interleukin-6 variations on the cardiovascular prognosis of patients with chronic renal disease.
    Goicoechea M; Quiroga B; García de Vinuesa S; Verdalles U; Reque J; Panizo N; Arroyo D; Santos A; Macías N; Luño J
    Ren Fail; 2012; 34(8):1002-9. PubMed ID: 22746155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRP, but not TNF-α or IL-6, decreases after weight loss in patients with morbid obesity exposed to intensive weight reduction and balneological treatment.
    Rość D; Adamczyk P; Boinska J; Szafkowski R; Ponikowska I; Stankowska K; Góralczyk B; Ruszkowska-Ciastek B
    J Zhejiang Univ Sci B; 2015 May; 16(5):404-11. PubMed ID: 25990058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between post-treatment circulating biomarkers of inflammation and survival among stage II-III colorectal cancer patients.
    Hua X; Kratz M; Malen RC; Dai JY; Lindström S; Zheng Y; Newcomb PA
    Br J Cancer; 2021 Sep; 125(6):806-815. PubMed ID: 34230610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory markers as related to disease severity in patients with chronic heart failure: limited effects of exercise training.
    Byrkjeland R; Nilsson BB; Westheim AS; Arnesen H; Seljeflot I
    Scand J Clin Lab Invest; 2011 Nov; 71(7):598-605. PubMed ID: 21831004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative serum C-reactive protein and its prognostic significance in patients with stage III-IV colorectal cancer.
    Lumachi F; Basso SM; Santeufemia DA; Ermani M; Lo Re G; Chiara GB
    Anticancer Res; 2014 Dec; 34(12):7263-6. PubMed ID: 25503158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating levels of C-reactive protein, interleukin-6 and tumor necrosis factor-α and risk of colorectal adenomas: a meta-analysis.
    Zhang X; Liu S; Zhou Y
    Oncotarget; 2016 Sep; 7(39):64371-64379. PubMed ID: 27608842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer.
    Dymicka-Piekarska V; Matowicka-Karna J; Gryko M; Kemona-Chetnik I; Kemona H
    Thromb Res; 2007; 120(4):585-90. PubMed ID: 17169411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers.
    Wang T; Rohan TE; Gunter MJ; Xue X; Wactawski-Wende J; Rajpathak SN; Cushman M; Strickler HD; Kaplan RC; Wassertheil-Smoller S; Scherer PE; Ho GY
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):971-7. PubMed ID: 21415362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers.
    Toriola AT; Cheng TY; Neuhouser ML; Wener MH; Zheng Y; Brown E; Miller JW; Song X; Beresford SA; Gunter MJ; Caudill MA; Ulrich CM
    Int J Cancer; 2013 Jun; 132(11):2648-58. PubMed ID: 23161620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies.
    Zeng F; Wei H; Yeoh E; Zhang Z; Ren ZF; Colditz GA; Tworoger SS; Su X
    Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1231-9. PubMed ID: 27277846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.